Embecta Corp. Common Stock (EMBC) is a publicly traded Healthcare sector company. As of November 20, 2026, EMBC trades at $6.09 with a market cap of $345.06M and a P/E ratio of 3.43. EMBC moved -1.53% today. Year to date, EMBC is -46.69%; over the trailing twelve months it is -56.19%. Its 52-week range spans $2.77 to $15.55. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces EMBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for EMBC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $6.09 |
| Market Cap | $345.06M |
| P/E Ratio | 3.43 |
| EPS | $1.64 |
| Dividend Yield | 0.01% |
| 52-Week High | $15.55 |
| 52-Week Low | $2.77 |
| Volume | 332.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.08B |
| Net Income | $95.40M |
| Gross Margin | 62.64% |
1 analysts cover EMBC: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.